146 related articles for article (PubMed ID: 10473104)
1. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y
Clin Cancer Res; 1999 Aug; 5(8):2185-91. PubMed ID: 10473104
[TBL] [Abstract][Full Text] [Related]
2. [Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Basaki Y; Yonekura K; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Aoyagi K; Yamada Y
Gan To Kagaku Ryoho; 2000 Jan; 27(1):93-8. PubMed ID: 10660738
[TBL] [Abstract][Full Text] [Related]
3. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
4. UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Basaki Y; Aoyagi K; Chikahisa L; Miyadera K; Hashimoto A; Yonekura K; Okabe S; Shibata J; Wierzba K; Yamada Y
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):68-71. PubMed ID: 11098498
[TBL] [Abstract][Full Text] [Related]
5. [Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Basaki Y; Shibata J; Murakami K; Hashimoto A; Yonekura K; Fukushima M; Yamada Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1607-12. PubMed ID: 10553418
[TBL] [Abstract][Full Text] [Related]
6. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Fujioka T; Hasegawa M; Ishikura K; Nomura K; Okamoto T; Tanji S; Koike H; Kubo T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2031-6. PubMed ID: 2221926
[TBL] [Abstract][Full Text] [Related]
8. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
10. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Suzuki M; Sekiguchi I; Tamada T; Nishida M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
[TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S
Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768
[TBL] [Abstract][Full Text] [Related]
15. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462
[TBL] [Abstract][Full Text] [Related]
16. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice.
Shibata J; Murakami K; Abe M; Hashimoto A; Utsugi T; Fukushima M; Yamada Y
Anticancer Res; 1998; 18(2A):1203-9. PubMed ID: 9615789
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y
Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
[TBL] [Abstract][Full Text] [Related]
18. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
19. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]